Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
120 participants
INTERVENTIONAL
2008-05-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hysteroscopy and Misoprostol Project
NCT00363389
Dose Comparison of Misoprostol for Cervix Ripening Before Operative Hysteroscopy.
NCT04152317
Misoprostol Administration Before Operative Hysteroscopy
NCT01805115
Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women
NCT05696574
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
NCT03638856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vaginal misoprostol
vaginal misoprostol was administered to this group of nulliparous women
misoprostol
400ug vaginally the day before surgery
oral misoprostol
oral misoprostol
oral misoprostol
400ug misoprostol orally the day before the surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
misoprostol
400ug vaginally the day before surgery
oral misoprostol
400ug misoprostol orally the day before the surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
the 1st Affiliated Hospital of Wenzhou Medical College
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feng Lin
Role: PRINCIPAL_INVESTIGATOR
the 1st affiliated hospital of Wenzhou Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the 1st Affiliated Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WenzhouMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.